Continue reading Stack3d

Introducing the reduced tingle and lower dose TriBsyn beta-alanine from the makers of CarnoSyn

Introducing Tribsyn

CarnoSyn is the way to go when you want premium beta-alanine, and that has been the case for several years. The brand genuinely helped put the performance and endurance-powering ingredient on the map and has even expanded on its original effort to SR CarnoSyn, a sustained-release version. Natural Alternatives International, the team behind CarnoSyn, has now created something genuinely innovative and easily one of the most impressive new ingredients we’ve seen in some time with TribSyn.

TriBsyn is beta-alanine infused with a proprietary technology that significantly increases the bioavailability of the popular ingredient, and at the same time, it eliminates the infamous paresthesia side effect, or what most people refer to as the beta-alanine tingle. The increased efficiency of TriBsyn allows for the groundbreaking benefit of achieving the same signature benefits beta-alanine has become known for with a much smaller amount, and Natural Alternatives International has specifics to back that up.

Basically there are two extremely important differences with TriBsyn compared to CarnoSyn as well as standard beta-alanine. Firstly, the reduced tingling is something some competitors have tried but didn’t do overly well with; in the case of TriBsyn, it has measured a reduction of about 70%. The other side of the coin is the incredible bioavailability where, according to Natural Alternatives International, you can have just under a third of the dose to have the same effect. The company specifically says 386mg of TriBsyn matches that of 1.2g of regular beta-alanine, which scales up to 1.029g versus the common 3.2g.

You can find out more about the CarnoSyn creator Natural Alternatives International’s newest innovation on its website at tribsyn.com, where you can also reach out to the team with any questions or how to get the ingredient in your next supplement. With the impressive benefits of the patent-pending TriBsyn, we expect to see several products come to market utilizing it, especially with the reduced dose giving it the ability to go into capsules and shrinking the overall serving and weight of complex offerings.